Aurobindo Pharma has terminated its licensing agreement with Hilleman Laboratories Singapore for a paediatric pentavalent ...

Aurobindo Pharma on Wednesday said its subsidiary has terminated a license agreement with Singapore-based Hilleman ...

Hyderabad: Aurobindo Pharma has announced that Auro Vaccines Private Limited, a wholly owned step-down subsidiary of the ...

Brokerage firm Elara is positive on the shares of Aurobindo Pharma Limited. The broking firm said that the Kakinada plant ...

The inspection took place from February 10-18, wherein the US regulator concluded with five procedural observations for Aurobindo Pharma's arm Eugia Steriles ...

U.S. FDA classifies Aurobindo Pharma warehouse in New Jersey as Official Action Indicated, impacting compliance and ...

Indian drugmaker Aurobindo Pharma reported a lower third-quarter profit on Thursday, as a spike in expenses more than offset strong demand for its generic drugs.

IST, the barometer index, the S&P BSE Sensex, surged 456.61 points, or 0.62%, to 74,186.84. The Nifty 50 index added 169.60 points, or 0.76%, to 22,506.90.

AUROBINDO PHARMA - TERMINATION OF LICENSE AGREEMENT WITH HILLEMAN LABORATORIES SINGAPORE PTE * AUROBINDO PHARMA - TERMINATION OF AGREEMENT BY AURO VACCINES ...

Aurobindo Pharma's subsidiary terminates pentavalent vaccine agreement with Hilleman Laboratories Singapore, no significant impact expected on company.

Aurobindo Pharma's subsidiary Auro Vaccines has terminated a license agreement with Singapore-based Hilleman Laboratories for ...